Precipio (PRPO) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $21.38, -5.17% vs the prior close of $22.54.
- Volume 95.13K shares, 0.8x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
PRPO slides 5.2% to $21.38, a 1-month low. Closed at $21.38, -5.17% vs the prior close of $22.54. Day range $21.38β$22.50, opened at $22.29.
PRPO daily analysis β what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 β PRPO slides 5.2% to $21.38, a 1-month low
- Closed at $21.38, -5.17% vs the prior close of $22.54. Day range $21.38β$22.50, opened at $22.29.
- Volume was 95.13K shares, 0.8x its 50-day average of 123.73K.
- Price is -16.1% vs its 50-day average ($25.47) and -15.2% vs its 200-day average ($25.19).
- 52-week range $16.40β$33.63; today's close sits at 29% of that range, 36.4% below the 52-week high.
Oct 15, 2026 β PRPO rises 1.3% to $22.54
- Closed at $22.54, +1.30% vs the prior close of $22.25. Day range $22.00β$22.81, opened at $22.24.
- Volume was 45.20K shares, 0.4x its 50-day average of 122.93K β lighter than usual.
- Price is -11.6% vs its 50-day average ($25.51) and -10.6% vs its 200-day average ($25.20).
- 52-week range $16.40β$33.63; today's close sits at 36% of that range, 33.0% below the 52-week high.
Oct 14, 2026 β PRPO dips 1.5% to $22.25, a 1-month low, 5 down days in a row
- Closed at $22.25, -1.51% vs the prior close of $22.59. Day range $22.15β$23.17, opened at $22.40.
- Volume was 42.50K shares, 0.3x its 50-day average of 122.74K β lighter than usual.
- Price is -12.8% vs its 50-day average ($25.53) and -11.7% vs its 200-day average ($25.21).
- 52-week range $16.40β$33.63; today's close sits at 34% of that range, 33.8% below the 52-week high.
- That makes 5 straight losses.
Oct 13, 2026 β PRPO ends flat (+0.0%) to $22.59, 4 down days in a row
- Closed at $22.59, +0.00% vs the prior close of $22.59. Day range $21.94β$23.00, opened at $22.57.
- Volume was 30.00K shares, 0.2x its 50-day average of 124.40K β lighter than usual.
- Price is -11.5% vs its 50-day average ($25.54) and -10.4% vs its 200-day average ($25.22).
- 52-week range $16.40β$33.63; today's close sits at 36% of that range, 32.8% below the 52-week high.
- That makes 4 straight losses.
Oct 12, 2026 β PRPO dips 2.3% to $22.59, a 1-month low, 3 down days in a row
- Closed at $22.59, -2.29% vs the prior close of $23.12. Day range $22.19β$23.03, opened at $22.90.
- Volume was 12.00K shares, 0.1x its 50-day average of 124.58K β lighter than usual.
- Price is -11.5% vs its 50-day average ($25.53) and -10.4% vs its 200-day average ($25.22).
- 52-week range $16.40β$33.63; today's close sits at 36% of that range, 32.8% below the 52-week high.
- That makes 3 straight losses.
Oct 9, 2026 β PRPO dips 0.3% to $23.12
- Closed at $23.12, -0.30% vs the prior close of $23.19. Day range $22.96β$23.82, opened at $23.14.
- Volume was 22.20K shares, 0.2x its 50-day average of 127.12K β lighter than usual.
- Price is -9.4% vs its 50-day average ($25.51) and -8.3% vs its 200-day average ($25.23).
- 52-week range $16.40β$33.63; today's close sits at 39% of that range, 31.3% below the 52-week high.
Oct 8, 2026 β PRPO dips 1.4% to $23.19
- Closed at $23.19, -1.40% vs the prior close of $23.52. Day range $22.55β$23.72, opened at $23.23.
- Volume was 118.00K shares, 0.9x its 50-day average of 127.11K.
- Price is -9.0% vs its 50-day average ($25.47) and -8.1% vs its 200-day average ($25.23).
- 52-week range $16.40β$33.63; today's close sits at 39% of that range, 31.0% below the 52-week high.
Oct 7, 2026 β PRPO ends flat (+0.3%) to $23.52
- Closed at $23.52, +0.30% vs the prior close of $23.45. Day range $22.93β$24.03, opened at $22.95.
- Volume was 66.40K shares, 0.5x its 50-day average of 127.51K β lighter than usual.
- Price is -7.6% vs its 50-day average ($25.44) and -6.7% vs its 200-day average ($25.22).
- 52-week range $16.40β$33.63; today's close sits at 41% of that range, 30.1% below the 52-week high.
Oct 6, 2026 β PRPO dips 2.3% to $23.45
- Closed at $23.45, -2.29% vs the prior close of $24.00. Day range $23.30β$24.27, opened at $24.00.
- Volume was 18.20K shares, 0.1x its 50-day average of 130.89K β lighter than usual.
- Price is -7.8% vs its 50-day average ($25.43) and -7.0% vs its 200-day average ($25.22).
- 52-week range $16.40β$33.63; today's close sits at 41% of that range, 30.3% below the 52-week high.
Oct 5, 2026 β PRPO jumps 3.8% to $24.00
- Closed at $24.00, +3.76% vs the prior close of $23.13. Day range $22.90β$24.12, opened at $23.10.
- Volume was 43.50K shares, 0.3x its 50-day average of 130.79K β lighter than usual.
- Price is -5.6% vs its 50-day average ($25.42) and -4.8% vs its 200-day average ($25.22).
- 52-week range $16.40β$33.63; today's close sits at 44% of that range, 28.6% below the 52-week high.
Oct 2, 2026 β PRPO rises 1.8% to $23.13
- Closed at $23.13, +1.76% vs the prior close of $22.73. Day range $22.88β$23.95, opened at $22.96.
- Volume was 22.70K shares, 0.2x its 50-day average of 132.22K β lighter than usual.
- Price is -9.0% vs its 50-day average ($25.41) and -8.3% vs its 200-day average ($25.22).
- 52-week range $16.40β$33.63; today's close sits at 39% of that range, 31.2% below the 52-week high.
PRPO latest news & SEC filings
Every SEC filing by or about PRPO in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Aug 14, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 2.02 β Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 14, 2026 Β· Form 10-Q β Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $7.02M (prior year $5.63M) (+24.7% vs Jun 30, 2025)
- Net income: -$219.00K (prior year $74.00K) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.12 (prior year $0.05) (loss widened vs Jun 30, 2025)
Jul 31, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 7.01 β Released information under Regulation FD (e.g. a presentation or press release).
Jul 16, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 16, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 16, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Things to know before you trade PRPO
- Last results release: Aug 14, 2026 (8-K Item 2.02). Previous ones: Feb 27, 2026, May 15, 2025, Feb 28, 2022. Based on that rhythm, the next report is likely around Nov 13, 2026 β an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.35% (largest 9.2%).
- Liquidity: about 55.43K shares (β$1.18M) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $21.38 vs a range of $16.40β$33.63 (29% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 9 open-market buys, 16 sales; latest: Richard A Sandberg sold 900 shares on May 21, 2026.
- Latest filings: 8-K Aug 14, 2026; 10-Q Aug 14, 2026; 8-K Jul 31, 2026.
- Share count: 1.79M shares outstanding (Aug 10, 2026), +10.5% vs a year earlier β notable dilution.
- Listing: Nasdaq Β· industry: Laboratory Analytical Instruments.
PRPO market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 22.29 | 22.50 | 21.38 | 21.38 | 95.13K |
| Oct 15, 2026 | 22.24 | 22.81 | 22.00 | 22.54 | 45.20K |
| Oct 14, 2026 | 22.40 | 23.17 | 22.15 | 22.25 | 42.50K |
| Oct 13, 2026 | 22.57 | 23.00 | 21.94 | 22.59 | 30.00K |
| Oct 12, 2026 | 22.90 | 23.03 | 22.19 | 22.59 | 12.00K |
| Oct 9, 2026 | 23.14 | 23.82 | 22.96 | 23.12 | 22.20K |
| Oct 8, 2026 | 23.23 | 23.72 | 22.55 | 23.19 | 118.00K |
| Oct 7, 2026 | 22.95 | 24.03 | 22.93 | 23.52 | 66.40K |
| Oct 6, 2026 | 24.00 | 24.27 | 23.30 | 23.45 | 18.20K |
| Oct 5, 2026 | 23.10 | 24.12 | 22.90 | 24.00 | 43.50K |
| Oct 2, 2026 | 22.96 | 23.95 | 22.88 | 23.13 | 22.70K |
| Oct 1, 2026 | 23.79 | 23.83 | 22.45 | 22.73 | 13.90K |
| Sep 30, 2026 | 23.72 | 24.23 | 23.63 | 23.68 | 74.20K |
| Sep 29, 2026 | 23.70 | 23.75 | 22.90 | 23.58 | 63.10K |
| Sep 28, 2026 | 23.47 | 24.36 | 23.26 | 24.11 | 72.40K |
| Sep 25, 2026 | 24.33 | 24.62 | 23.45 | 23.65 | 52.30K |
| Sep 24, 2026 | 23.87 | 24.72 | 23.23 | 24.47 | 58.20K |
| Sep 23, 2026 | 26.22 | 26.31 | 23.58 | 23.84 | 39.70K |
| Sep 22, 2026 | 26.39 | 27.03 | 26.11 | 26.26 | 80.50K |
| Sep 21, 2026 | 26.50 | 26.80 | 26.00 | 26.79 | 138.40K |
About Precipio
Precipio (PRPO) is listed on the Nasdaq and classified by the SEC under βLaboratory Analytical Instrumentsβ. Its business address is in NEW HAVEN, CT. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1043961.
PRPO board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Ronald Asbury Andrews | Director | Jan 20, 2026 |
| David Seth Cohen | Director | Jul 16, 2026 |
| Jeffrey Cossman | Director | Jul 16, 2026 |
| Ilan Danieli | Chief Executive Officer | Jan 6, 2026 |
| Kathleen Laporte | Director | Jan 20, 2026 |
| Richard A Sandberg | Director | May 26, 2026 |
| Christina Rizopoulos Valauri | Director | Jul 16, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Ilan Danieli | Chief Executive Officer | Jan 6, 2026 |
| Matthew Gage | Chief Financial Officer | Jan 6, 2026 |
| Ahmed Zaki Sabet | Chief Operating Officer | Apr 10, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| May 21, 2026 | Richard A Sandberg | Sale | 900 | $25.02 |
| May 21, 2026 | Richard A Sandberg | Sale | 900 | $25.02 |
| May 21, 2026 | Richard A Sandberg | Sale | 900 | $25.02 |
| May 21, 2026 | Richard A Sandberg | Sale | 900 | $25.02 |
| May 20, 2026 | Richard A Sandberg | Sale | 2,034 | $24.89 |
| May 20, 2026 | Richard A Sandberg | Sale | 500 | $25.00 |
| May 20, 2026 | Richard A Sandberg | Sale | 2,034 | $24.89 |
| May 20, 2026 | Richard A Sandberg | Sale | 500 | $25.00 |
| May 20, 2026 | Richard A Sandberg | Sale | 2,034 | $24.89 |
| May 20, 2026 | Richard A Sandberg | Sale | 500 | $25.00 |
| May 20, 2026 | Richard A Sandberg | Sale | 2,034 | $24.89 |
| May 20, 2026 | Richard A Sandberg | Sale | 500 | $25.00 |
| May 19, 2026 | Richard A Sandberg | Sale | 600 | $24.42 |
| May 19, 2026 | Richard A Sandberg | Sale | 600 | $24.42 |
| May 19, 2026 | Richard A Sandberg | Sale | 600 | $24.42 |
PRPO financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $24.25M | $-363.00K | -0.23 | $685.00K |
| Dec 31, 2024 | $18.58M | $-4.29M | -2.93 | $439.00K |
| Dec 31, 2023 | $15.41M | β | -4.51 | $-3.56M |
| Dec 31, 2022 | $9.82M | β | -10.73 | $-7.72M |
| Dec 31, 2021 | $8.70M | β | -0.40 | $-6.58M |
Latest balance sheet: total assets $21.32M, total liabilities $6.56M, cash $3.08M (as of Jun 30, 2026).
PRPO earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 14, 2026 | 8-K Item 2.02 (results) | $23.50 |
| Feb 27, 2026 | 8-K Item 2.02 (results) | $24.08 |
| May 15, 2025 | 8-K Item 2.02 (results) | $7.15 |
| Feb 28, 2022 | 8-K Item 2.02 (results) | β |
| Jul 28, 2021 | 8-K Item 2.02 (results) | β |
| Jul 22, 2020 | 8-K Item 2.02 (results) | β |
| Feb 14, 2019 | 8-K Item 2.02 (results) | β |
| Oct 16, 2018 | 8-K Item 2.02 (results) | β |
| Jul 18, 2018 | 8-K Item 2.02 (results) | β |
| May 14, 2018 | 8-K Item 2.02 (results) | β |
| Feb 9, 2018 | 8-K Item 2.02 (results) | β |
| Nov 21, 2017 | 8-K Item 2.02 (results) | β |
Related stocks Β· Laboratory Analytical Instruments
Illumina (ILMN)Agilent Technologies (A)Waters (WAT)10x Genomics (TXG)Mettler Toledo International Inc/ (MTD)Revvity (RVTY)Avantor (AVTR)Bruker (BRKR)Bio-Rad Laboratories (BIO)Pacific Biosciences Of California (PACB)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on PRPO
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.